+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diabetic Eye Disease Devices Market - Global Forecast 2025-2030- Product Image
Diabetic Eye Disease Devices Market - Global Forecast 2025-2030- Product Image
Sale

Diabetic Eye Disease Devices Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015430
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Diabetic Eye Disease Devices Market grew from USD 18.92 billion in 2024 to USD 20.81 billion in 2025. It is expected to continue growing at a CAGR of 9.70%, reaching USD 32.99 billion by 2030.

Charting the Course of Diabetic Eye Disease Device Evolution and Market Dynamics Driving Innovation, Patient Care Enhancements, and Strategic Opportunities

The diabetic eye disease devices market stands at the intersection of rapidly advancing technologies and growing clinical imperatives, offering unprecedented opportunities to enhance patient care and streamline physician workflows. From initial diagnostic imaging to therapeutic interventions, the devices that support detection and treatment are becoming increasingly sophisticated, reflecting deeper collaboration among clinicians, engineers, and data scientists.

Amid rising diabetes prevalence globally, early diagnosis and timely management of complications such as diabetic retinopathy and macular edema are more critical than ever. This introductory overview outlines how converging trends-including the integration of artificial intelligence, the refinement of imaging modalities, and the expansion of minimally invasive therapies-are reshaping the landscape. By understanding these foundational forces, stakeholders can anticipate market shifts, prioritize research investments, and optimize clinical pathways to deliver better outcomes.

Unveiling Groundbreaking Technological and Therapeutic Transformations Poised to Revolutionize Diabetic Eye Disease Management and Access

A wave of transformative shifts is redefining every stage of the diabetic eye disease device continuum, from development pipelines to point-of-care deployment. Artificial intelligence algorithms are increasingly embedded in imaging systems, enabling lesion detection and disease staging that surpass traditional human interpretation. Simultaneously, the marriage of multimodal imaging-combining spectral and swept-source optical coherence tomography with ultra-widefield fundus photography-provides clinicians with a more holistic view of retinal pathology.

On the therapeutic front, injectable agents and laser platforms are evolving toward greater precision and patient comfort. Microincision instruments are reducing procedure times and recovery windows, while next-generation implantable devices promise sustained drug release with fewer clinic visits. These technological breakthroughs are paralleled by shifting reimbursement frameworks and emerging partnerships between device manufacturers and digital health pioneers. Together, these forces are accelerating adoption and broadening access to advanced diabetic eye care worldwide.

Analyzing the Strategic Repercussions of 2025 United States Tariffs on Supply Chains, Pricing Dynamics, and Competitive Positioning in the Diabetic Eye Device Sector

The implementation of United States tariffs in 2025 has introduced a new variable into the global supply chain calculus for diabetic eye disease devices, influencing pricing strategies, sourcing decisions, and competitive positioning. Manufacturers are reevaluating component origins, diversifying supplier networks to mitigate exposure, and absorbing selective cost increases to preserve market share. In parallel, some established players have strategically relocated portions of their production to tariff-exempt jurisdictions, ensuring continuity of supply to key markets.

These adjustments have not been uniform across the device spectrum. High-value imaging systems, which depend on advanced optics and semiconductors, have borne a more pronounced share of tariff-related cost pressures, prompting incremental price revisions in certain regions. Meanwhile, consumables such as injectable delivery systems and laser accessories have seen more moderate impacts, as manufacturers leverage economies of scale and lean manufacturing methodologies. Despite these headwinds, the overarching commitment to innovation and patient-centric design remains undiminished, with several organizations announcing new product launches slated for the post-tariff era.

Illuminating the Distinctive Market Drivers and Opportunities Across Technology Platforms, Clinical Applications, and Distribution Ecosystems in Diabetic Eye Care

Segment-specific nuances reveal how technology, device type, end user, application, and distribution channel collectively shape market trajectories and investment priorities. Within technology, fundus cameras-spanning mydriatic, nonmydriatic, and ultra-widefield variants-continue to command broad clinical reliance, while spectral, swept-source, and time-domain optical coherence tomography platforms deepen diagnostic confidence through enhanced resolution and penetration. Ultrasound imaging remains vital for complex cases, differentiated by A-scan and B-scan capabilities, and fluorescein and indocyanine green angiography retain indispensable roles in vascular assessment.

When viewed through the lens of device type, imaging systems and both AI-based and conventional software anchor the diagnostic category, as endolaser probes and microincision instruments define surgical interventions, and therapeutic offerings range from anti-VEGF and steroid injection devices to argon and diode laser systems and emerging implantable formats. End users span ambulatory surgical centers-whether single-specialty or multi-specialty-clinics from ophthalmology-specific to broader multi-specialty practices, government and private hospitals, and both public and private research institutes. Clinically, the delicate balance between managing diffuse and focal macular edema and addressing nonproliferative or proliferative retinopathy underpins application strategies. Finally, distribution pathways-from direct website or OEM sales to distributor networks, online channels, and retail pharmacies-determine how swiftly innovations reach caregivers and patients alike.

Navigating Regional Market Variations and Tailoring Strategic Launch Plans to Diverse Healthcare Systems and Economic Contexts

Geographic dynamics underscore how regional healthcare infrastructures, regulatory environments, and funding mechanisms influence adoption and innovation. In the Americas, robust R&D ecosystems and well-established reimbursement frameworks support early uptake of advanced imaging and minimally invasive therapies, while large patient populations drive demand for scalable solutions. Within Europe, the Middle East, and Africa, heterogeneous market maturity and variable public funding models necessitate tailored go-to-market approaches, with some nations prioritizing cost-effectiveness and others rapidly embracing premium device launches.

Across Asia-Pacific, a mosaic of emerging economies and highly developed markets fosters both volume-driven strategies and premium segment breakthroughs. Localization of manufacturing and adaptive pricing models enable broader reach in price-sensitive regions, even as leading urban centers invest heavily in state-of-the-art ophthalmic clinics and research initiatives. Collectively, these regional contours inform global commercialization plans, with top-tier companies deploying differentiated portfolios to align with each territory’s unique clinical and economic priorities.

Examining Competitive Strategies and Collaborative Initiatives That Accelerate Innovation and Strengthen Market Positions Among Leading and Emerging Device Manufacturers

Key industry players are leveraging complementary strengths in R&D, strategic alliances, and operational scale to fortify their market positions. Leading imaging manufacturers continue to expand their AI-enabled software suites through acquisitions and in-house innovation, while surgical instrument specialists are forging partnerships with laser and injectable technology providers to deliver integrated treatment platforms. Several established device companies have also entered value-based care agreements with large healthcare networks, aligning reimbursement with clinical outcomes and driving broader access to advanced interventions.

Emerging challengers are capitalizing on niche applications, such as sustained-release implantable therapeutics and portable imaging systems optimized for teleophthalmology. Their agility in product development and targeted clinical studies is enabling them to secure footholds in select markets, compelling incumbents to accelerate their own innovation roadmaps. Across the competitive landscape, the convergence of digital health, precision medicine, and patient-centric service models is reshaping how companies define value and engage providers.

Implementing Strategic Investments in AI, Supply Chain Diversification, and Outcome-Based Partnerships to Strengthen Diabetic Eye Care Market Leadership

To navigate the evolving environment, industry stakeholders should prioritize several actionable steps. First, investing in interoperable AI-driven diagnostics and telehealth integrations can accelerate clinician adoption and expand screening initiatives, particularly in underserved regions. Second, diversification of manufacturing footprints and supply chain partners will mitigate tariff-related risks and enhance resilience against future disruptions. Third, engaging payers and health systems through outcome-based payment models can align incentives and support wider uptake of high-impact therapies.

Additionally, co-development partnerships with academic research institutes and technology startups can infuse fresh perspectives and expedite product development cycles. Finally, tailoring market access strategies to regional regulatory frameworks and reimbursement landscapes will ensure optimal resource allocation and more predictable launch outcomes. By adopting these recommendations, device companies and healthcare providers can collectively drive sustainable growth and improved patient outcomes in diabetic eye care.

Detailing Rigorous Mixed-Methods Research Processes Combining Expert Interviews, Secondary Analysis, and Cross-Validation to Ensure Unbiased Market Insights

This study synthesizes primary interviews with leading clinicians, device executives, and payers, complemented by comprehensive secondary research from peer-reviewed journals, regulatory filings, and patent databases. Quantitative data were analyzed to identify emerging technology adoption rates, while qualitative insights enabled a deeper understanding of clinical workflow integration and payer value perceptions. Cross-validation techniques ensured that tariff impact assessments and segmentation analyses accurately reflect current market realities.

Regional dynamics were examined through a combination of localized expert consultations and country-specific policy reviews. Competitive benchmarking incorporated publicly available financial disclosures, investor presentations, and conference proceedings to map product pipelines and strategic alliances. Finally, rigorous editorial oversight and fact-checking processes were employed to maintain the highest standards of accuracy and relevance throughout the research.

Synthesizing Market Dynamics, Technological Advances, and Strategic Responses to Illuminate Future Pathways for Diabetic Eye Disease Device Innovation

In summary, the diabetic eye disease devices market is in a phase of dynamic transformation driven by technological innovation, regulatory shifts, and evolving clinical paradigms. While tariff-related challenges necessitate strategic recalibrations in supply chain and pricing, the overarching trend toward AI-led diagnostics, minimally invasive therapies, and value-based care underscores the sector’s long-term growth potential.

Stakeholders equipped with a nuanced understanding of segmentation nuances, regional market idiosyncrasies, and competitive trajectories will be best positioned to navigate uncertainties and capitalize on emerging opportunities. As device manufacturers, healthcare providers, and investors collaborate to refine care pathways and optimize resource allocation, the ultimate beneficiary will be the millions of individuals at risk of vision loss due to diabetic eye disease.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Technology
    • Fluorescein Angiography
    • Fundus Camera
      • Mydriatic Fundus Camera
      • Nonmydriatic Fundus Camera
      • Ultra-widefield Fundus Camera
    • Indocyanine Green Angiography
    • Optical Coherence Tomography
      • Spectral Domain Optical Coherence Tomography
      • Swept Source Optical Coherence Tomography
      • Time Domain Optical Coherence Tomography
    • Ultrasound Imaging
      • A-Scan
      • B-Scan
  • Device Type
    • Diagnostic Devices
      • Imaging Systems
      • Software
        • AI-Based Software
        • Conventional Software
    • Surgical Instruments
      • Endolaser Probes
      • Microincision Instruments
    • Therapeutic Devices
      • Implantable Devices
      • Injection Devices
        • Anti-VEGF Injection Devices
        • Steroid Injection Devices
      • Laser Systems
        • Argon Laser
        • Diode Laser
  • End User
    • Ambulatory Surgical Centers
      • Multi-specialty Centers
      • Single-specialty Centers
    • Clinics
      • Multi-specialty Clinics
      • Ophthalmology Clinics
    • Hospitals
      • Government Hospitals
      • Private Hospitals
    • Research Institutes
      • Private Research Institutes
      • Public Research Institutes
  • Application
    • Diabetic Macular Edema
      • Diffuse Macular Edema
      • Focal Macular Edema
    • Diabetic Retinopathy
      • Nonproliferative Diabetic Retinopathy
      • Proliferative Diabetic Retinopathy
  • Distribution Channel
    • Direct Sales
      • Company Website Sales
      • OEM Direct Sales
    • Indirect Sales
      • Distributors
      • Online Channels
      • Retail Pharmacies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:

  • Carl Zeiss Meditec AG
  • Topcon Corporation
  • Heidelberg Engineering GmbH
  • NIDEK Co., Ltd.
  • Canon Medical Systems Corporation
  • Optos plc
  • Optovue, Inc.
  • Alcon Inc.
  • Bausch + Lomb Corporation
  • Johnson & Johnson Vision Care, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of smartphone-based retinal imaging systems for early diabetic retinopathy screening
5.2. Adoption of artificial intelligence algorithms to detect and grade diabetic retinopathy lesions
5.3. Development of portable optical coherence tomography devices for point-of-care diabetic retinal assessment
5.4. Advancements in sustained-release intravitreal implants targeting chronic diabetic macular edema management
5.5. Integration of teleophthalmology platforms with cloud-based health records for remote diabetic eye care delivery
5.6. Clinical validation of gene therapy candidates aimed at halting progression of diabetic retinopathy pathology
5.7. Regulatory approvals and market entry of biosimilar anti-VEGF treatments to address diabetic macular edema access
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Diabetic Eye Disease Devices Market, by Technology
8.1. Introduction
8.2. Fluorescein Angiography
8.3. Fundus Camera
8.3.1. Mydriatic Fundus Camera
8.3.2. Nonmydriatic Fundus Camera
8.3.3. Ultra-widefield Fundus Camera
8.4. Indocyanine Green Angiography
8.5. Optical Coherence Tomography
8.5.1. Spectral Domain Optical Coherence Tomography
8.5.2. Swept Source Optical Coherence Tomography
8.5.3. Time Domain Optical Coherence Tomography
8.6. Ultrasound Imaging
8.6.1. A-Scan
8.6.2. B-Scan
9. Diabetic Eye Disease Devices Market, by Device Type
9.1. Introduction
9.2. Diagnostic Devices
9.2.1. Imaging Systems
9.2.2. Software
9.2.2.1. AI-Based Software
9.2.2.2. Conventional Software
9.3. Surgical Instruments
9.3.1. Endolaser Probes
9.3.2. Microincision Instruments
9.4. Therapeutic Devices
9.4.1. Implantable Devices
9.4.2. Injection Devices
9.4.2.1. Anti-VEGF Injection Devices
9.4.2.2. Steroid Injection Devices
9.4.3. Laser Systems
9.4.3.1. Argon Laser
9.4.3.2. Diode Laser
10. Diabetic Eye Disease Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. Multi-specialty Centers
10.2.2. Single-specialty Centers
10.3. Clinics
10.3.1. Multi-specialty Clinics
10.3.2. Ophthalmology Clinics
10.4. Hospitals
10.4.1. Government Hospitals
10.4.2. Private Hospitals
10.5. Research Institutes
10.5.1. Private Research Institutes
10.5.2. Public Research Institutes
11. Diabetic Eye Disease Devices Market, by Application
11.1. Introduction
11.2. Diabetic Macular Edema
11.2.1. Diffuse Macular Edema
11.2.2. Focal Macular Edema
11.3. Diabetic Retinopathy
11.3.1. Nonproliferative Diabetic Retinopathy
11.3.2. Proliferative Diabetic Retinopathy
12. Diabetic Eye Disease Devices Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.2.1. Company Website Sales
12.2.2. OEM Direct Sales
12.3. Indirect Sales
12.3.1. Distributors
12.3.2. Online Channels
12.3.3. Retail Pharmacies
13. Americas Diabetic Eye Disease Devices Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Diabetic Eye Disease Devices Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Diabetic Eye Disease Devices Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Carl Zeiss Meditec AG
16.3.2. Topcon Corporation
16.3.3. Heidelberg Engineering GmbH
16.3.4. NIDEK Co., Ltd.
16.3.5. Canon Medical Systems Corporation
16.3.6. Optos plc
16.3.7. Optovue, Inc.
16.3.8. Alcon Inc.
16.3.9. Bausch + Lomb Corporation
16.3.10. Johnson & Johnson Vision Care, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DIABETIC EYE DISEASE DEVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DIABETIC EYE DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DIABETIC EYE DISEASE DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. DIABETIC EYE DISEASE DEVICES MARKET: RESEARCHAI
FIGURE 26. DIABETIC EYE DISEASE DEVICES MARKET: RESEARCHSTATISTICS
FIGURE 27. DIABETIC EYE DISEASE DEVICES MARKET: RESEARCHCONTACTS
FIGURE 28. DIABETIC EYE DISEASE DEVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DIABETIC EYE DISEASE DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FLUORESCEIN ANGIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FLUORESCEIN ANGIOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FUNDUS CAMERA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FUNDUS CAMERA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY MYDRIATIC FUNDUS CAMERA, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY MYDRIATIC FUNDUS CAMERA, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY NONMYDRIATIC FUNDUS CAMERA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY NONMYDRIATIC FUNDUS CAMERA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ULTRA-WIDEFIELD FUNDUS CAMERA, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ULTRA-WIDEFIELD FUNDUS CAMERA, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FUNDUS CAMERA, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FUNDUS CAMERA, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDOCYANINE GREEN ANGIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDOCYANINE GREEN ANGIOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TIME DOMAIN OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TIME DOMAIN OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY A-SCAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY A-SCAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY B-SCAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY B-SCAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AI-BASED SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AI-BASED SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ENDOLASER PROBES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ENDOLASER PROBES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY MICROINCISION INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY MICROINCISION INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INJECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INJECTION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ANTI-VEGF INJECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ANTI-VEGF INJECTION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STEROID INJECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STEROID INJECTION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ARGON LASER, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ARGON LASER, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIODE LASER, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIODE LASER, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY MULTI-SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY MULTI-SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SINGLE-SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SINGLE-SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PUBLIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PUBLIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIFFUSE MACULAR EDEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIFFUSE MACULAR EDEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FOCAL MACULAR EDEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FOCAL MACULAR EDEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY NONPROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY NONPROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COMPANY WEBSITE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COMPANY WEBSITE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OEM DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OEM DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FUNDUS CAMERA, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FUNDUS CAMERA, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FUNDUS CAMERA, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FUNDUS CAMERA, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 253. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FUNDUS CAMERA, 2018-2024 (USD MILLION)
TABLE 256. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FUNDUS CAMERA, 2025-2030 (USD MILLION)
TABLE 257. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 258. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 259. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, 2018-2024 (USD MILLION)
TABLE 260. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, 2025-2030 (USD MILLION)
TABLE 261. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 262. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 263. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
TABLE 264. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2030 (USD MILLION)
TABLE 265. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 266. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 267. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 268. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 269. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
TABLE 270. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2030 (USD MILLION)
TABLE 271. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 272. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 273. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2024 (USD MILLION)
TABLE 274. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2025-2030 (USD MILLION)
TABLE 275. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 278. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 279. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 280. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 281. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 282. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 283. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 284. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 285. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2018-2024 (USD MILLION)
TABLE 288. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA, 2025-2030 (USD MILLION)
TABLE 289. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2024 (USD MILLION)
TABLE 290. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2025-2030 (USD MILLION)
TABLE 291. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 294. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 295. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 296. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY IND

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Diabetic Eye Disease Devices market report include:
  • Carl Zeiss Meditec AG
  • Topcon Corporation
  • Heidelberg Engineering GmbH
  • NIDEK Co., Ltd.
  • Canon Medical Systems Corporation
  • Optos plc
  • Optovue, Inc.
  • Alcon Inc.
  • Bausch + Lomb Corporation
  • Johnson & Johnson Vision Care, Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 20.81 Billion
Forecasted Market Value ( USD ) by 2030 $ 32.99 Billion
Compound Annual Growth Rate9.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Diabetic Eye Disease Devices - Global Strategic Business Report - Product Image

Diabetic Eye Disease Devices - Global Strategic Business Report

  • Report
  • 270 Pages
  • Global
From
Dry Eye Disease Market Report 2025-2034 - Product Image

Dry Eye Disease Market Report 2025-2034

  • Report
  • 400 Pages
  • Global
From
Thyroid Eye Disease Treatments Market - Global Forecast 2025-2030 - Product Image

Thyroid Eye Disease Treatments Market - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Immunosuppressive Therapy for Eye Diseases Market - Global Forecast 2025-2030 - Product Image

Immunosuppressive Therapy for Eye Diseases Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Dry Eye Disease Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Dry Eye Disease Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From

About the Diabetic Eye Disease Devices Market

Within the realm of optics, the diabetic eye disease devices market encompasses a range of medical devices and equipment designed for the screening, diagnosis, management, and treatment of eye conditions associated with diabetes. One of the most common complications of diabetes is diabetic retinopathy, which can lead to deterioration in vision and, ultimately, blindness if left untreated. Consequently, the market for diabetic eye disease devices includes but is not limited to fundus cameras, OCT (optical coherence tomography) devices, fluorescein angiography equipment, laser treatment devices, and retinal screening systems. These devices aid eye care professionals in monitoring the progression of retinal diseases, facilitating early detection, and providing therapeutic interventions that can preserve vision. Innovations in this sector often focus on enhancing imaging capabilities, improving patient comfort, and integrating with health informatics systems to streamline the workflow in ophthalmic clinics. Several notable companies operating within the diabetic eye disease devices market include Topcon Corporation, which provides imaging and laser systems for eye care; Carl Zeiss AG, known for their optical and optoelectronic technology; and Optos plc, which offers ultra-widefield retinal imaging devices. Other key players in this sector are Canon Inc., focusing on digital imaging, and NIDEK Co., Ltd., which manufactures comprehensive eye examination and treatment devices. These companies are among the leaders in advancing the technology that supports eye care professionals in managing diabetes-related eye diseases. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.